By Joan Faus BARCELONA (Reuters) - Spanish pharmaceutical firm Almirall forecast on Monday a drop in core earnings this year after a 15.8% decline in .
Almirall achieves core net sales of €633.8 MM Euros in the first nine months of 2022 showing a solid 5.3% growth Almirall continues solid business momentum in Q3 with an acceleration of sales
Almirall s Nine-month 2022 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.